1. Current Challenges in Pharmacovigilance: Pragmatic Approaches. Report of CIOMS Working Group V, CIOMS, Geneva, 2001.
2. Signal Selection and Follow-Up in Pharmacovigilance
3. Guidance for Industry: Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment. FDA, 2005. http://www.fda.gov/cber/gdlns/pharmacovig.pdf.
4. Guidance for Industry Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs. ICH, 2004. http://www.fda.gov/cber/gdlns/ichclinsafety.pdf.
5. Post-Marketing Surveillance: Drug Epidemiology